Imaging of tumour response to immunotherapy | European Radiology Experimental | Full Text
Immunotherapy and targeted therapy combinations in metastatic breast cancer - The Lancet Oncology
PDF) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | ResearchGate
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development - ScienceDirect
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? | Journal for ImmunoTherapy of Cancer | Full Text
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Early Screening of Pancreatic Cancer Immunotherapy Target Candidates | Technology Networks
Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - Rezasoltani - 2021 - Cancer Medicine - Wiley Online Library
The future of cancer immunotherapy: microenvironment-targeting combinations | Cell Research
Systemic Immunity Is Required for Effective Cancer Immunotherapy - ScienceDirect
Profiling of immune features to predict immunotherapy efficacy
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors | Biomarker Research | Full Text
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy: Trends in Immunology
Frontiers | Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
Enhancing anti-tumour efficacy with immunotherapy combinations - The Lancet
Combining microenvironment normalization strategies to improve cancer immunotherapy | PNAS
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy | Nature Reviews Cancer
Frontiers | Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | Nature Biotechnology
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer - Annals of Oncology
What Are Some Signs That Immunotherapy Treatment Is Working? - GoodRx
Biomarkers in Cancer Immunotherapy - Cancer Research Institute
